---
schema_version: "secwatch.filing_event.v1"
accession: "0001824293-24-000094"
form_type: "8-K"
ticker: "GRI"
cik: "0001824293"
company_name: "GRI Bio, Inc."
filed_at: "2024-07-26T23:59:59+00:00"
generated_at: "2026-05-31T15:59:42.542619+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# GRI Bio increases ATM offering capacity to $2.64M, reports $961K already sold

## Summary
- Maximum aggregate gross proceeds from ATM offering raised to $2,644,609 via prospectus supplement filed July 26, 2024.
- Approximately $961,272 of shares have already been sold under the May 20, 2024 Sales Agreement with H.C. Wainwright & Co.
- Shares are common stock, par value $0.0001 per share; proceeds used for general corporate purposes.

## SEC filing metadata
- accession: 0001824293-24-000094
- form_type: 8-K
- ticker: GRI
- cik: 0001824293
- company_name: GRI Bio, Inc.
- filed_at: 2024-07-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1824293/000182429324000094/0001824293-24-000094-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1824293/000182429324000094/val-20240726.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001824293-24-000094
- JSON: https://secwatch.observer/filing/0001824293-24-000094.json
- Plain text: https://secwatch.observer/filing/0001824293-24-000094.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
